248 related articles for article (PubMed ID: 16931536)
1. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Black JA; Liu S; Hains BC; Saab CY; Waxman SG
Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
[TBL] [Abstract][Full Text] [Related]
2. Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
Black JA; Waxman SG
J Neurol Sci; 2008 Nov; 274(1-2):57-63. PubMed ID: 18485368
[TBL] [Abstract][Full Text] [Related]
3. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
Lo AC; Saab CY; Black JA; Waxman SG
J Neurophysiol; 2003 Nov; 90(5):3566-71. PubMed ID: 12904334
[TBL] [Abstract][Full Text] [Related]
4. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
5. Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
Black JA; Liu S; Carrithers M; Carrithers LM; Waxman SG
Ann Neurol; 2007 Jul; 62(1):21-33. PubMed ID: 17654737
[TBL] [Abstract][Full Text] [Related]
6. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
[TBL] [Abstract][Full Text] [Related]
7. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
8. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI.
Hains BC; Saab CY; Lo AC; Waxman SG
Exp Neurol; 2004 Aug; 188(2):365-77. PubMed ID: 15246836
[TBL] [Abstract][Full Text] [Related]
9. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
Papadopoulos D; Pham-Dinh D; Reynolds R
Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
[TBL] [Abstract][Full Text] [Related]
10. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
Bannerman PG; Hahn A
J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
[TBL] [Abstract][Full Text] [Related]
11. Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Liu S; Zwinger P; Black JA; Waxman SG
J Neurol Sci; 2014 Jun; 341(1-2):8-12. PubMed ID: 24690348
[TBL] [Abstract][Full Text] [Related]
12. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
13. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Herrero-Herranz E; Pardo LA; Gold R; Linker RA
Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.
Lo AC; Black JA; Waxman SG
Neuroreport; 2002 Oct; 13(15):1909-12. PubMed ID: 12395089
[TBL] [Abstract][Full Text] [Related]
15. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
Chan J; Ban EJ; Chun KH; Wang S; McQualter J; Bernard C; Toh BH; Alderuccio F
Autoimmunity; 2008 Aug; 41(5):405-13. PubMed ID: 18568646
[TBL] [Abstract][Full Text] [Related]
16. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis.
Brand-Schieber E; Werner P
Exp Neurol; 2004 Sep; 189(1):5-9. PubMed ID: 15296830
[TBL] [Abstract][Full Text] [Related]
18. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3).
Mattner F; Smiroldo S; Galbiati F; Muller M; Di Lucia P; Poliani PL; Martino G; Panina-Bordignon P; Adorini L
Eur J Immunol; 2000 Feb; 30(2):498-508. PubMed ID: 10671205
[TBL] [Abstract][Full Text] [Related]
20. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
Papadopoulos D; Rundle J; Patel R; Marshall I; Stretton J; Eaton R; Richardson JC; Gonzalez MI; Philpott KL; Reynolds R
J Neurosci Res; 2010 Feb; 88(2):346-59. PubMed ID: 19658199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]